# Magnesium Supplementation to Prevent Bone Loss

> **NCT00346658** · PHASE1 · COMPLETED · sponsor: **University of Tennessee** · enrollment: 74 (—)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** magnesium

## Key facts

- **NCT ID:** NCT00346658
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 74 (—)
- **Last updated:** 2008-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346658, "Magnesium Supplementation to Prevent Bone Loss". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00346658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*